Inventure — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Avenue Biosciences develops machine learning-enabled chemistry and software to accelerate the discovery and manufacturing of protein biologics for the biotechnology and therapeutics industry.
AI & Machine LearningBiotechDeep TechHelsinki, FI
Ville Paavilainen(Co-founder & Research Director)Alastalo(MD, PhD)Rosti(PhD, eMBA)
Co-investorsBalnord Sp. z o.o.Voima Ventures
MONCYTE Health develops a personalized diagnostic test that helps clinicians choose more effective cholesterol-lowering treatments for patients with high cholesterol.
BiotechDigital HealthHealthtech
Simon Pfisterer(CSO & Founder)inTamara Alagirova(CEO & Founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Reveel Technologies Oy
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.